149369
Carcinoma of the urinary bladder in a tertiary care setting in a developing country
Wednesday, November 7, 2007: 1:05 PM
Farhana Badar
,
Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan
Ambreen Sattar
,
Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan
Fouzia Meerza
,
Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan
Noreen Irfan
,
Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan
Neelam Siddiqui
,
Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan
Objectives: To determine the epidemiologic features of urinary bladder cancer cases presenting at a cancer hospital, from Dec. 1994 through Dec. 2004. Patients and methods: Six-hundred and seven medical records were evaluated retrospectively at the Shaukat Khanum Memorial Cancer Hospital. Gender, age, histologic types, grade, stage, symptoms, risk factors, and patient follow-up were studied. Staging was done through the American Joint Commission on Cancer's criteria. Class of Case was established using the Facility Oncology Registry Data Standards, 2004. Results: Mean age: 55.5 years; men: 83%. Transitional cell- in 86%, squamous cell- in 4%, adeno- in 3%, and undifferentiated carcinoma in 7% of the cases. Stage: II in 18.3%, I in 17.3%, III in 14.2%, IV in 26%, 0 in 6.3%, and not evaluable in 17.8% of the cases. Grades: G3 in 37.9%, G2 in 25.2%, G1 in 9.7%, G3 in 2.8%, and undetermined in 24.4% of the subjects. Commonest presenting symptom: hematuria in 54.7% men and 52.9% women; risk factor: positive smoking history in nearly 35% males and 2% females. Average interval between diagnosis and last contact: 26.5 months; for analytic cases, 34.9 months. Conclusion: Urinary bladder cancer was seen primarily in males; transitional cell type was dominant. Majority of the patients were symptomatic; smoking history was recorded mostly in men. Further, a change in the staging system to the Collaborative Staging methodology would be useful in addressing the concerns in the public health sector about data reproducibility over time and to use it for surveillance purposes.
Learning Objectives: 1. To describe the disease and patient characteristics of urinary bladder cancer in a developing country.
2. To study if there are similarities in features between developing and developed countries.
3. To emphasize the use of collaborative staging to enable the use of data for surveillance purpose.
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|